Odile Launay

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial

Jean-Louis Bresson, Christian Perronne, Odile Launay et al. · The Lancet · 2006 · 412 citations

Vaccination, Vaccine Safety, Vaccine Development +5

Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study

Françoise Dromer, Simone Mathoulin‐Pélissier, Odile Launay et al. · PLoS Medicine · 2007 · 376 citations · Full text

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France

Pierre Verger, Lisa Fressard, Fanny Collange et al. · EBioMedicine · 2015 · 332 citations · Full text

Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness

Ann R. Falsey, Janet E. McElhaney, Gerrit A. van Essen et al. · The Journal of Infectious Diseases · 2014 · 284 citations · Full text